Ranitidine 150 mg tablets, 130 count bottles, NDC 37808-196-04.
Published January 15, 2020 · Recall initiated: December 26, 2019
Summary
FDA records drug Class II recall D-0646-2020, published January 15, 2020 and initiated December 26, 2019. Recalling firm: AAA Pharmaceutical, Inc.; Status: Terminated; Reported quantity: 31,536 (130-count bottles); Lot: P134457, Sept 2020 P135156, Aug 2020 P135156, Aug 2020 P135243, Aug 2020 P135877, Sept 2020 P136145, Aug 2020 P136146, Sept 2020 P136623, April 2021 P136728, April, 2021 P136994, April, 2021 P137348, April, 2021 P137423, April, 2021 P137499, April, 2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- AAA Pharmaceutical, Inc.
- Distributor
- Product was distributed to one consignee who may have distributed the product further to their retail stores.
- Lot
- P134457, Sept 2020 P135156, Aug 2020 P135156, Aug 2020 P135243, Aug 2020 P135877, Sept 2020 P136145, Aug 2020 P136146, Sept 2020 P136623, April 2021 P136728, April, 2021 P136994, April, 2021 P137348, April, 2021 P137423, April, 2021 P137499, April, 2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADiscount Drug Mart, Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg /Antihistamine, Indoor/OutdoorMarch 11, 2020
- FDARanitidine 150 mg tablets, 24 count bottles, NDC 37808-196-01.January 15, 2020
- FDARanitidine Capsules 300 mg, 30 count bottles. Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJJanuary 15, 2020
- FDAGlenmark Ranitidine Tablets USP 150 mg Rx Only 500 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd.January 15, 2020
- FDARanitidine Capsules 150 mg, (a) 60 count bottles (NDC 62559-690-60) , (b) 500 count bottles (NDCJanuary 15, 2020
- FDASmart Sense Regular Strength Aspirin Tablets, 325 mg packed in a) 100 count UPC 8-8397-38781-6 and b) 500August 14, 2019
Questions about this recall
Was Ranitidine 150 mg tablets, 130 count bottles, NDC 37808-196-04. recalled?
Yes. FDA published recall D-0646-2020 on January 15, 2020. Reported hazard: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
What should I do if I have this product?
Voluntary: Firm initiated · Letter